Skip to main content

Find Clinical Trials

Home
Conditions
Anemia, Refractory

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

73 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

NCT00022048

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome

NCT00003171

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

NCT00521430

Conditions: Anemia, Anemia, Aplastic, Anemia, Refractory, +76 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome

NCT00030550

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: PPD Development Wilmington, North Carolina, United States

View Trial Details

Completed

Thalidomide in Treating Patients With Myelodysplastic Syndrome

NCT00015990

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00002798

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome

NCT00003959

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer

NCT00012376

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +46 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome

NCT00005598

Conditions: Anemia, Anemia, Refractory, Bone Marrow Diseases, +3 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00005622

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details